A vaccination is in the works
Fortunately, there are numerous researchers looking to develop such a vaccine. At the University of Kansas School of Engineering and School of Pharmacy, scientists are attempting to develop an effective vaccine or drug therapy that can be used for the prevention of EBV. They have been awarded a $1.8 million grant over the court of five years from the National Institutes of Health, enabling them to work on such a project.
Of course, developing the vaccination of drug therapy is not the only step. FDA approval is crucial, as they have the ability to cease a drug that could quite possibly have the power to prevent the EBV infection if it is deemed unsafe for some other factor. So, there is still much to be done, but progress seems to be headed in the right track.
If and when researchers, either at the University of Kansas or elsewhere, are able to develop a vaccination or drug therapy against the EBV infection, as Bebo points out, we will likely see a drastic drop in the rates of MS.